tradingkey.logo
tradingkey.logo
Search

Natus Launches Locally Manufactured Nicolet EDX System in China

PR NewswireSep 15, 2026 1:49 PM
facebooktwitterlinkedin
View all comments0

SUZHOU, China, Sept. 15, 2026 /PRNewswire/ -- Natus Medical Incorporated, the world's largest pure-play neurodiagnostic company, today announced the launch of the Nicolet EDX EMG system in the People's Republic of China, marking the first Natus product manufactured and sold in the PRC.


China has always been a critical geography for Natus, and our new locally manufactured capability builds on our long history of partnership with leading hospitals across China," said Walter Wang, General Manager, China. "Through our market-leading distribution network, we are strengthening access to advanced Natus neurodiagnostic technologies and services for clinicians and patients in China.

Nicolet EDX is the most comprehensive Natus EMG system, delivering industry-leading performance and advanced capabilities healthcare organizations rely on for confident diagnostic decision-making. On June 18, Nicolet EDX became the first locally manufactured Natus product registered in China after receiving final approval from the National Medical Products Administration.

The launch of the Nicolet EDX system marks an important milestone in the long-term commitment Natus has to China, where healthcare procurement increasingly prioritizes locally manufactured medical technologies. This launch positions Natus to better support hospitals, distributors, clinicians, and patients across the country.

"China has always been a critical geography for Natus, and our new locally manufactured capability builds on our long history of partnership with leading hospitals across China," said Walter Wang, General Manager, China. "Through our market-leading distribution network, we are strengthening access to advanced Natus neurodiagnostic technologies and services for clinicians and patients in China."

Designed for routine EMG examinations, complex neuromuscular cases, and advanced diagnostic workflows, Nicolet EDX gives clinicians a comprehensive and scalable platform for confident testing and diagnosis.

"This milestone represents far more than local production. It brings together Natus' global vision, standards, technology and experience with talent, insight and capabilities through our team in China," said Wang. "It also demonstrates our long-term commitment to the clinicians and patients we serve in China."

The EDX system is built in the new Natus office in Suzhou, a historic city that has become one of Eastern China's industrial hubs. Natus will hold a ceremony in Suzhou on October 27, celebrating the collaboration of this new site and product launch milestone in China.

ABOUT NATUS 

Natus is trusted by healthcare providers around the globe as the solution source to screen, diagnose, and treat disorders affecting the brain and neural pathways. The best-in-class Natus solutions, including service, field support, and education, enable clinicians to advance their standard of care, improving patient outcomes and quality of life. For more information on Natus, please visit natus.com/neuro.

CONTACT INFORMATION:  
Lisa Schuler
Phone: +1 612 528-1332
Email: lisa.schuler@natus.com

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.